Previous 10 | Next 10 |
home / stock / seovf / seovf news
Sernova ([[SEOVF]] +61.9%) announces that its principal clinical investigator, presented additional positive preliminary safety and efficacy data for its diabetes Cell Pouch at the 2021 American Society of Transplant Surgeons Winter Symposium.Sernova’s Cell Pouch transplante...
(TheNewswire) Sernova’s Cell Pouch System shows sustained clinical benefit in study patients with type 1 diabetes through multiple efficacy indicators and ongoing safety and tolerability LONDON, ONTARIO – TheNewswire - January 15, 2021 &...
(TheNewswire) December 18, 2020 - 9:00 a.m. EST LONDON, ONTARIO - TheNewswire – December 18, 2020 – Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, today announces that Dr....
(TheNewswire) London, Ontario - TheNewswire – December 16, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) continues to gain attention this week as the company shares have reached new levels over the past few days. Dr. Philip Toleikis, President an...
(TheNewswire) LONDON, ONTARIO – TheNewswire - December 11, 2020 – At the request of IIROC (“Investment Industry Regulatory Organization of Canada”), Sernova Corp. (“Sernova” or the “Company”) (TSX-V:SV...
(TheNewswire) London, Ontario - TheNewswire - December 3 , 2020 - Interest in Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH) is growing rapidly. With its medical advances and latest announcements, Sernova has garnered attention in the fields of regenerati...
(TheNewswire) LONDON, ONTARIO - TheNewswire - November 30, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF ) (FSE:PSH), a leading clinical-stage regenerative medicine therapeutics company, is pleased to announce that Dr. Piotr Witkowski, principal investigator...
(TheNewswire) - 5 of 7 study patients implanted with Cell Pouch and cell transplants ongoing; full enrollment on track for early 2021 - Treated patients continue to demonstrate enduring safety indicators and blood levels of insulin (C-peptide) p...
(TheNewswire) L ondon, Ontario - TheNewswire - October 30, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company, announces that, subject to acceptance by the TSX Venture Exchange, it intends to ex...
(TheNewswire) LONDON, ONTARIO - TheNewswire - October 29, 2020 - Sernova Corp. (TSXV:SVA) (OTC:SEOVF) (FSE:PSH), a clinical-stage regenerative medicine company, was invited by the TMX Group to present today at the first-ever TSX Life Sciences Investor D...
News, Short Squeeze, Breakout and More Instantly...
(TheNewswire) To date Sernova reports 7 patients in its Phase I/II type 1 diabetes clinical trial achieved freedom from insulin injections and demonstrate blood sugar control in the non- diabetic range (HbA1c 6.5%); 6 patients have reached between 5.5 and 50 months o...
(TheNewswire) LONDON, Ontario; BOSTON, Massachusetts – June 12, 2024 – TheNewswire – Sernova Corp. (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA:PSH), a clinical-stage biotechnology company focused on the development of regenerative medicine cell therapies for treatmen...
Orbital Infrastructure Group Inc. (OIGBQ) is expected to report for Q1 2024 OFS Credit Company Inc. (OCCI) is expected to report for Q2 2024 KBC Groupe NV ADR (KBCSY) is expected to report for Q1 2024 Daikin Industries Ltd ADR (DKILY) is expected to report $0.11 for Q4 2024 Invita...